Johnny Yao

Company: Voyager Therapeutics

Job title: Director - Pharmacology & Translational Research

Seminars:

Navigating Several Aspects of Preclinical Studies to Improve Translational Safety & Success of AAV Gene Therapies 10:00 am

• Delving into de-targeting of AAV vectors to minimize safety concerns • Highlighting concerns relating to AAV toxicity in NHP studies and possible methods to mitigate potential toxicity during in life study • Exploring how to optimally use animal models to detect early signs of toxicityRead more

day: Day One